AAAAAA

   
Results: 1-12 |
Results: 12
Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a metaanalysis of the randomised trials
Authors: Eikelboom, JW Quinlan, DJ Douketis, JD
Citation: Jw. Eikelboom et al., Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a metaanalysis of the randomised trials, LANCET, 358(9275), 2001, pp. 9-15
Acute renal vein thrombosis, oral contraceptive use, and hyperhomocysteinemia
Authors: Chan, HHW Douketis, JD Nowaczyk, MJM
Citation: Hhw. Chan et al., Acute renal vein thrombosis, oral contraceptive use, and hyperhomocysteinemia, MAYO CLIN P, 76(2), 2001, pp. 212-214
Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis?
Authors: Douketis, JD Crowther, MA Foster, GA Ginsberg, JS
Citation: Jd. Douketis et al., Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis?, AM J MED, 110(7), 2001, pp. 515-519
Perioperative anticoagulation in patients with chronic atrial fibrillationwho are undergoing elective surgery: Results of a physician survey
Authors: Douketis, JD Crowther, MA Cherian, SS
Citation: Jd. Douketis et al., Perioperative anticoagulation in patients with chronic atrial fibrillationwho are undergoing elective surgery: Results of a physician survey, CAN J CARD, 16(3), 2000, pp. 326-330
The effects of hormone replacement therapy on thrombin generation, fibrinolysis inhibition, and resistance to activated protein C: Prospective cohortstudy and review of the literature
Authors: Douketis, JD Gordon, M Johnston, M Julian, JA Adachi, JR Ginsberg, JS
Citation: Jd. Douketis et al., The effects of hormone replacement therapy on thrombin generation, fibrinolysis inhibition, and resistance to activated protein C: Prospective cohortstudy and review of the literature, THROMB RES, 99(1), 2000, pp. 25-34
Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy
Authors: Douketis, JD Foster, GA Crowther, MA Prins, MH Ginsberg, JS
Citation: Jd. Douketis et al., Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy, ARCH IN MED, 160(22), 2000, pp. 3431-3436
A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism - Examining some unanswered questions regarding location of treatment, product type, and dosing frequency
Authors: Dolovich, LR Ginsberg, JS Douketis, JD Holbrook, AM Cheah, G
Citation: Lr. Dolovich et al., A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism - Examining some unanswered questions regarding location of treatment, product type, and dosing frequency, ARCH IN MED, 160(2), 2000, pp. 181-188
Incorporating preventive care recommendations into clinical practice: How do we bridge the gap?
Authors: Douketis, JD
Citation: Jd. Douketis, Incorporating preventive care recommendations into clinical practice: How do we bridge the gap?, CAN MED A J, 160(8), 1999, pp. 1171-1172
Periodic health examination, 1999 update: 1. Detection, prevention and treatment of obesity
Authors: Douketis, JD Feightner, JW Attia, J Feldman, WF
Citation: Jd. Douketis et al., Periodic health examination, 1999 update: 1. Detection, prevention and treatment of obesity, CAN MED A J, 160(4), 1999, pp. 513-525
Understanding obesity
Authors: Douketis, JD
Citation: Jd. Douketis, Understanding obesity, CAN MED A J, 160(13), 1999, pp. 1820-1821
The effects of low-intensity warfarin on coagulation activation in patients with antiphospholipid antibodies and systemic lupus erythematosus
Authors: Douketis, JD Crowther, MA Julian, JA Stewart, K Donovan, D Kaminska, EA Laskin, CA Ginsberg, JS
Citation: Jd. Douketis et al., The effects of low-intensity warfarin on coagulation activation in patients with antiphospholipid antibodies and systemic lupus erythematosus, THROMB HAEM, 82(3), 1999, pp. 1028-1032
Physician preferences for perioperative anticoagulation in patients with amechanical heart valve who are undergoing elective noncardiac surgery
Authors: Douketis, JD Crowther, MA Cherian, SS Kearon, CB
Citation: Jd. Douketis et al., Physician preferences for perioperative anticoagulation in patients with amechanical heart valve who are undergoing elective noncardiac surgery, CHEST, 116(5), 1999, pp. 1240-1246
Risultati: 1-12 |